retatrutide blindness Retatrutide, an experimental weight-loss drug, has not been approved by the FDA. But, doctors and nurse practitioners in clinics across the country are prescribing it anyway, a CBS News investigation Retatrutide Australia | Is Retatrutide

Its no secret that GLP-1 drugs like Ozempic and Wegovy are dominating headlines and prescriptions

For those looking to attack stubborn fat, this one shines

Retatrutide + MOTS-c Dosing Protocol & Schedule Evidence-level notice No clinical trial has tested retatrutide + MOTS-c together

And finally, prediabetic patients, regardless of the dose you essentially had about a 90-95% chance of reverting to normoglycemia with retatrutide, this is in line with tirzepatide and is just further proof that glucagon agonism isnt adding anything deleterious to blood glucose control in these patients

Slowed gastric transit affects the entire digestive system, including colonic motility